Fair Value Calculator Fair Value Calculator
EN DE

Lichen International Limited (LICN) Fair Value & Analysis

Industrials · US · Market cap $35.7M

LI Lichen International Limited logo Lichen International Limited LICN · US
Price$1.32
Fair Value$1.91
Upside+44.7%
Quality31/100
Watch Lichen International Limited for free, get notified when fair value or trend changes. Watch for free
Evidence: Low Range $1.26 – $2.38

Fair value as of: Jul 17, 2026

From 1 valuation models · updated today

Fair value updated Jul 17, 2026, revised from $19.44 to $1.91 (−90.2%) since Jun 24, 2026. Share price −61.4% over the past month.

Price vs Fair Value (12 months)

$8.63 $0.8404 Fair Value $1.91 Jul 2025 Jul 2026

12‑month range $0.8404 – $8.63 · fair‑value band $1.26 – $2.38 · the $1.32 price screens below the $1.91 fair value. As of Jul 17, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Lichen International Limited (LICN) currently trades at $1.32, while our model-based Fair Value estimate is $1.91, implying the stock looks roughly 44.7% undervalued today. We read business quality at 31/100 (below-average quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.

Over the trailing twelve months, Lichen International Limited generated revenue of $24.5M at a net margin of -89.6%. Revenue declined 56.1% year over year. It earns a return on equity of -29.8%. The balance sheet holds a net cash position of $26.4M. Fundamentals as of Jul 17, 2026

Our scenario range runs from $1.26 (bear case) to $2.38 (bull case); at $1.32, the current price sits within that range. For context, the median of 10 Industrials peers we cover trades at -35% fair-value upside, at 45%, LICN screens cheaper than that median.

Key figures & financial health

Revenue (TTM) $24.5M
Revenue growth (YoY) -56.1%
Net margin -89.6%
Return on equity -29.8%
Free cash flow −$17.8M FY2025
Operating margin -89.3%
More key figures
EPS (TTM) $-4.02
EPS growth (YoY) -51.3%
Net cash $26.4M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 17, 2026. TTM = trailing twelve months.

About the company

Lichen International Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China. The company offers financial and taxation-related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation services; and education support services, including marketing, operational, and technical support, as well as the sale of teaching and learning materials. It also provides software and maintenance services, including the sale of financial and taxation analysis software, and financial and taxation training software, as well as offers software installation, training, and after-sales technical and maintenance support services. The company serves listed companies, state-owned enterprises, government authorities, and other business enterprises, including small and medium-sized enterprises. The company was …

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Lichen International Limited reported revenue of $24.5M in FY2025 versus $34.3M in FY2021, a compound −8.0%/yr. Reported net income was −$22.0M in FY2025.

Revenue −8.0%/yr
FY21 $34.3M
FY22 $33.8M
FY23 $39.8M
FY24 $41.5M
FY25 $24.5M
Net income
FY21 $8.5M
FY22 $7.8M
FY23 $8.3M
FY24 −$6.1M
FY25 −$22.0M

Is LICN fairly valued? → Check now

📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog, it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Lichen International Limited Fair Value". https://www.fairvalue-calculator.com/stock/LICN

Similar stocks

10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).

Stock Price Fair Value vs Fair Value
Cintas Corporation CTAS $180.40 $74.70 -59%
RELX PLC REN €28.40 €14.15 -50%
Thomson Reuters Corporation TRI C$108.50 C$70.40 -35%
Copart, Inc CPRT $30.77 $28.89 -6%
RB Global, Inc RBA C$147.38 C$65.61 -55%
Global Payments Inc GPN $74.03 $34.31 -54%
UL Solutions Inc ULS $97.38 $29.61 -70%
Brambles Limited BMBLF $13.42 $12.25 -9%
Wolters Kluwer N.V WKL €61.14 €57.13 -7%
Rentokil Initial plc RTO $28.35 $19.63 -31%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Lichen International Limited (LICN) undervalued?
As of Jul 17, 2026, our model estimates a fair value of $1.91 versus a price of $1.32, about +45% (undervalued). Model-based estimate, not financial advice.
What is the fair value of LICN?
Our model-based fair value for Lichen International Limited is $1.91 (as of Jul 17, 2026), built from audited fundamentals. The current price is $1.32.
What is the quality score of LICN?
Lichen International Limited has a Quality Score of 31/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Lichen International Limited (LICN)?
Lichen International Limited reported trailing-twelve-month revenue of about $24.5M (latest available figure, as of Jul 17, 2026).
What is the net profit margin of LICN?
The net profit margin of Lichen International Limited is about -89.6%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

Free alert · no account needed

Tell me when Lichen International Limited reaches its Fair Value

Just your email, and we'll notify you when the price and Fair Value of Lichen International Limited materially change. Free bonus: the monthly Top-25 report of the most undervalued quality stocks.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.